Impedance Measurements in Heart Failure Patients

NCT01509495 — Phase 1, Terminated, 20 participants, Medtronic BRC

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT01509495, acronym SIM-HF
StatusTerminated - Enrollment rate too low; rate much under estimation of sponsor and investigators
PhasePhase 1
Study typeInterventional; na, single group, masking: none, diagnostic
Enrollment20 (Estimated)
SponsorMedtronic BRC (Industry)
ConditionsHeart Failure
InterventionsAkern BIA101 and Custom Device (Device)
Datesstart 2011-12-01, primary completion 2014-05-01, completion 2014-05-01, first posted 2012-01-13, last updated 2014-07-04
Locations3 sites in Czechia, Germany, Slovakia

Related Papers Related Patents Related Grants Related Experts
All trials for Heart Failure All trials of Akern BIA101 and Custom Device

-Summary

The purpose of this study is to measure impedance during inpatient treatment.

Expand all sections  ·  Collapse all

+Arms and interventions

  • Akern BIA101 and Custom Device (Device): Impedance Measurement every 4 hours

+Outcome measures

Primary outcomes

  • Impedance Measurement of Patients in Heart Failure, impedance change first to last measurement [every 4 hours up to 48 hours]

Secondary outcomes

  • Accuracy of Respiratory rate determined by impedance measurements [every 4 hours up to 48 hours]
  • Correlation between hemodynamic (central venous or arterial pressure) and impedance measurements (optional) [every 4 hours up to 48 hours]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* patients admitted to hospital for symptoms of congestive heart failure
* patients older than 18 years
* patients willing and able to give informed consent

Exclusion Criteria:

* patients who will require adrenergic or positive inotropic medications
* patients enrolled in a concurrent study that may confound the results of this study
* patients unable or unwilling to participate in study procedures
* patients who are pregnant
* patients who are mentally handicapped or legal incompetent
* patients who are dependent on investigator or sponsor

+Locations (3)

FacilityCityCountryStatus
Nemocnice Na HomolcePragueCzechia
Universitätsklinik Würzburg, Medizinische Klinik und Poliklinik IWürzburg, FrankenGermany
NUSCHBratislavaSlovakia

+Investigators

  • Sebastian KG Maier, Prof., Principal investigator, Klinikum St. Elisabeth Straubing, Med. Klinik II, St.-Elisabeth-Str. 23, 94315 Straubing, Germany
  • Eva Goncalvesova, Prof., Principal investigator, NUSCH, Cardiac Surgery, Pod Krasnou horkou 1, 83348 Bratislava, Slovakia
  • Petr Neuzil, Prof., Principal investigator, Nemocnice Na Homolce, Cardiology, Roentgenova 2/37, 150 30 Praha 5, Czechia